One FTSE 100 stock I’d buy and one I’d sell today

Royston Wild looks at two FTSE 100 (INDEXFTSE: UKX) stocks with very different growth outlooks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Hargreaves Lansdown (LSE: HL) saw its share price duck marginally in Tuesday trade following a muted response to full-year numbers. The stock was last 1% lower on the day.

The FTSE 100 company advised that net new business outflows charged 15% higher during the 12 months to June 2017, to £6.9bn, a result that powered assets under administration 28% higher to £79.2bn. And the firm saw the number of active customers on its books balloon by 118,000 year-on-year, to 954,000.

Net revenues rose 18% from fiscal 2016, to £385.6m, while pre-tax profit cantered 21% higher to £265.8m.

Commenting on last year’s results, chief executive Chris Hill said: “We have had a good year for gathering new clients and assets as a result of our relentless focus on the exceptional service we provide.  Key to this has been understanding the needs of our clients and expanding our range of solutions and services to help them.

There are considerable challenges for people in the current saving and investment environment but there are also opportunities, and Hargreaves Lansdown is ideally placed to help people make their investment decisions with confidence.” 

Pacy profits growth on the cards

The City certainly doesn’t expect it to run out of steam any time soon, and analysts have chalked in an 11% earnings rise for 2018.

These forecasts do not make the Footsie star appear too attractive on paper, however, Hargreaves Lansdown sporting a prospective P/E ratio of 27.2 times. Still, I think the company’s resilience in the face of tough market conditions warrants such a premium, as does the massive revenues potential of its ever-expanding product suite and fast-improving digital operations.

Furthermore, the number crunchers are also expecting dividends to ignite again following last year’s disappointing outcome. The Bristol business was not able to pay a special dividend in 2017 after the Financial Conduct Authority said it would reassess the company’s regulatory capital requirements given its “strong recent growth in scale and complexity.”

While there still remains some uncertainty around this issue, the number crunchers anticipate that Hargreaves Lansdown will loosen the pursestrings again this year in light of its strong cash generation and hot earnings outlook. As a consequence, total rewards of 45.7p per share are expected, up from 29p last year, and meaning that the asset manager offers a chunky 3.4% yield.

A textbook sell

I am not so convinced by the growth outlook over at Pearson (LSE: PSON) and am tipping the Footsie business to carry on struggling for some time yet.

City analysts expect the company to report a second successive earnings fall in 2017, an 18% drop currently being forecast. And it is easy to see this trend continuing give the colossal structural troubles in its core markets, as student enrolment levels in North America steadily decline and those in higher education increasingly switch from buying expensive textbooks to renting them, or seeking cheaper materials online.

So despite its conventionally-low forward P/E ratio of 12.9 times, I believe the company is still not worth the risk right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Hargreaves Lansdown. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »